OLIVI, MATTEO
 Distribuzione geografica
Continente #
NA - Nord America 170
EU - Europa 88
AS - Asia 78
AF - Africa 2
Totale 338
Nazione #
US - Stati Uniti d'America 169
SG - Singapore 60
IT - Italia 37
IE - Irlanda 18
SE - Svezia 13
DE - Germania 8
CN - Cina 7
IN - India 4
UA - Ucraina 3
AL - Albania 2
FI - Finlandia 2
ID - Indonesia 2
JP - Giappone 2
MA - Marocco 2
AM - Armenia 1
BY - Bielorussia 1
CZ - Repubblica Ceca 1
ES - Italia 1
KR - Corea 1
MD - Moldavia 1
PA - Panama 1
PT - Portogallo 1
UZ - Uzbekistan 1
Totale 338
Città #
Singapore 53
Santa Clara 43
Chandler 34
Dublin 18
Turin 16
Nyköping 9
Columbus 8
Torino 8
Medford 6
Munich 5
Milan 4
Princeton 4
Ashburn 3
Chennai 3
Beijing 2
Fairfield 2
Guangzhou 2
Hangzhou 2
Honolulu 2
Jakarta 2
Los Angeles 2
Rome 2
Tirana 2
Ann Arbor 1
Bolzano 1
Boydton 1
Brno 1
Cambridge 1
Cheyenne 1
Empoli 1
Falkenstein 1
Grottaglie 1
Hamburg 1
Helsinki 1
Houston 1
Kurume 1
Lappeenranta 1
Lisbon 1
Marrakesh 1
Mumbai 1
Nuremberg 1
Panama City 1
Rabat 1
Rochester 1
San Jose 1
Seoul 1
Tokyo 1
Upper Marlboro 1
Yerevan 1
Zaragoza 1
Totale 259
Nome #
Daratumumab with or without chemotherapy in relapsed and refractory acute lymphoblastic leukemia. A retrospective observational Campus Acute Lymphoblastic Leukemia study 71
Immunomodulatory and clinical effects of daratumumab in T-cell acute lymphoblastic leukaemia 67
Frequency and risk factors for thrombosis in acute myeloid leukemia and high-risk myelodysplastic syndromes treated with intensive chemotherapy: a two centers observational study 59
Evolving therapeutic approaches for older patients with acute myeloid leukemia in 2021 44
Sorafenib in combination with intensive chemotherapy for relapsed or refractory FLT3-ITD positive acute myeloid leukemia: A two centers experience 25
An IDO1-related immune gene signature predicts overall survival in acute myeloid leukemia 20
MEC (mitoxantrone, etoposide, and cytarabine) induces complete remission and is an effective bridge to transplant in acute myeloid leukemia 19
Validation of SIE/SIES/GITMO consensus criteria for unfitness to predict early mortality and survival in acute myeloid leukaemia patients treated with hypomethylating agents and venetoclax 19
Thrombosis in Acute Myeloid Leukemia: Pathogenesis, Risk Factors and Therapeutic Challenges 14
Safety profile and impact on survival of tyrosine kinase inhibitors versus conventional therapy in relapse or refractory FLT3 positive acute myeloid leukemia patients 12
Totale 350
Categoria #
all - tutte 1.915
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.915


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202118 0 0 0 0 0 0 6 4 2 0 2 4
2021/202242 0 0 1 1 1 3 0 0 6 5 15 10
2022/202392 8 11 1 11 7 28 4 4 8 2 6 2
2023/202453 6 3 9 2 2 6 1 0 2 2 5 15
2024/2025145 5 35 8 14 59 24 0 0 0 0 0 0
Totale 350